In vitro and in vivo activity of a novel c-Met-targeting antibody-drug conjugate using a DNA-alkylating, indolinobenzodiazepine payload

被引：7
|
作者：
Lai, Katharine C.
Muvaffak, Asli
Li, Min
Themeles, Marian
Sikka, Surina
Donahue, Kerry
Hicks, Stuart W.
Romanelli, Angela
Chittenden, Thomas
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-45
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
45
引用
收藏
页数：2
相关论文
共 50 条
  • [31] In vitro and in vivo activity of DHES0815A, an antibody-drug conjugate targeting HER2/neu in uterine serous carcinoma
    Tymon-Rosario, Joan
    Bonazzoli, Elena
    Guglielmi, Adele
    Bellone, Stefania
    Nagarkatti, Nupur
    Zammataro, Luca
    Zeybek, Burak
    Harold, Justin
    Mauricio, Dennis
    Clark, Mitchell
    Andikyan, Vaagn
    Huang, Gloria
    Altwerger, Gary
    Menderes, Gulden
    Azodi, Masoud
    Ratner, Elena
    Schwartz, Peter
    Santin, Alessandro
    GYNECOLOGIC ONCOLOGY, 2021, 162 : S186 - S187
  • [32] IMGN779, a CD33-Targeted Antibody-Drug Conjugate (ADC) with a Novel DNA-Alkylating Effector Molecule, Induces DNA Damage, Cell Cycle Arrest, and Apoptosis in AML Cells
    Krystal, Watkins M.
    Walker, Russell
    Fishkin, Nathan
    Audette, Charlene
    Kovtun, Yelena
    Romanelli, Angela
    BLOOD, 2015, 126 (23)
  • [33] Targeting FZD7-positive cancers using a novel antibody-drug conjugate.
    Do, Myan
    Wu, Christina C.
    Adams, Stephen
    Carson, Dennis
    Advani, Sunil
    Willert, Karl
    CANCER RESEARCH, 2021, 81 (13)
  • [34] In vitro and in vivo activity of an antibody-drug conjugate (IMMU-110) targeted against multiple myeloma
    Sapra, P
    Stein, R
    Pickett, J
    Govindan, S
    Cardillo, T
    Damoci, C
    Sheerin, A
    Horak, I
    Goldenberg, D
    Griffiths, G
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2004, 19 (04) : 515 - 516
  • [35] SHR-A1403, a novel c-Met antibody-drug conjugate, exerts encouraging anti-tumor activity in c-Met-overexpressing models
    Chang-yong Yang
    Lei Wang
    Xing Sun
    Mi Tang
    Hai-tian Quan
    Lian-shan Zhang
    Li-guang Lou
    Shao-hua Gou
    Acta Pharmacologica Sinica, 2019, 40 : 971 - 979
  • [36] SHR-A1403, a novel c-Met antibody-drug conjugate, exerts encouraging anti-tumor activity in c-Met-overexpressing models
    Yang, Chang-yong
    Wang, Lei
    Sun, Xing
    Tang, Mi
    Quan, Hai-tian
    Zhang, Lian-shan
    Lou, Li-guang
    Gou, Shao-hua
    ACTA PHARMACOLOGICA SINICA, 2019, 40 (07) : 971 - 979
  • [37] Development of novel MUC1-C targeting antibody-drug conjugate for pancreatic cancer treatment
    Ahmad, Rehan
    Panchamoorthy, Govind
    Raina, Deepak
    Lawney, Brian
    Kharbanda, Surender
    Jasuja, Ravi
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [38] Selectivity and Safety of VIP943: A Novel CD123-Targeting Antibody-Drug Conjugate (ADC) Using a Proprietary Linker and Payload Class
    Stelte-Ludwig, Beatrix
    Schomber, Tibor
    Izumi, Raquel
    Wong, Harvey
    Frigault, Melanie M.
    Rebstock, Anne-Sophie
    Ludwig, Sebastian
    Mithal, Arushi
    Johnson, Amy J.
    Hamdy, Ahmed
    BLOOD, 2023, 142
  • [39] Antibody-Drug Conjugates (ADCs) with novel IGN DNA-alkylating agents display potent antigen-specific activity against hematologic and solid tumor xenograft models.
    Whiteman, Kathleen
    Johnson, Holly
    Wilhelm, Alan
    Miller, Michael
    Li, Wei
    Reid, Emily
    Archer, Katie
    Fishkin, Nathan
    Dandeneau, Andre
    Maloney, Erin
    Pinkas, Jan
    Chari, Ravi
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [40] SYD985, a novel HER2-targeting antibody-drug conjugate in preclinical models for USC, both in vitro and in vivo.
    Black, Jonathan
    Lopez, Salvatore
    Cocco, Emiliano
    Bellone, Stefania
    Bonazzoli, Elena
    Schwab, Carlton
    English, Diana Peta-gay
    Goedings, Peter J.
    Beusker, Patrick
    van der Lee, Miranda
    Timmers, Marco
    Dokter, Wim
    Schwartz, Peter E.
    Santin, Alessandro
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12345